Marco A. Burgio
Meldola, 47014, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Dynamics of domestic cat hepatitis B virus infection in juvenile cats.
Journal: Veterinary microbiology
Published: November 20, 2025
Rare Driver Mutations in Advanced, Oncogene-Addicted Non-Small Cell Lung Cancer: A North Italian, Real-World, Registry Experience.
Journal: Diagnostics (Basel, Switzerland)
Published: March 25, 2024
Circulating Tumour Cells: Detection and Application in Advanced Non-Small Cell Lung Cancer.
Journal: International journal of molecular sciences
Published: September 25, 2023
The Clinical Significance of Circulating Tumor DNA for Minimal Residual Disease Identification in Early-Stage Non-Small Cell Lung Cancer.
Journal: Life (Basel, Switzerland)
Published: July 07, 2023
Malignant Pleural Mesothelioma: Preliminary Toxicity Results of Adjuvant Radiotherapy Hypofractionation in a Prospective Trial (MESO-RT).
Journal: Cancers
Published: January 16, 2023
Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC: The BEVERLY Multicenter Randomized Phase 3 Trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 11, 2022
High Levels of Circulating Monocytic Myeloid-Derived Suppressive-Like Cells Are Associated With the Primary Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: An Exploratory Analysis.
Journal: Frontiers in immunology
Published: January 31, 2022
Brigatinib in the first-line treatment of ALK+ metastatic NSCLC: safety and efficacy.
Journal: Expert review of anticancer therapy
Published: April 27, 2021
Immune Checkpoint Inhibitors With or Without Bone-Targeted Therapy in NSCLC Patients With Bone Metastases and Prognostic Significance of Neutrophil-to-Lymphocyte Ratio.
Journal: Frontiers in immunology
Published: April 19, 2021
Case Report: Stevens-Johnson Syndrome and Hepatotoxicity Induced by Osimertinib Sequential to Pembrolizumab in a Patient With EGFR-Mutated Lung Adenocarcinoma.
Journal: Frontiers in pharmacology
Published: February 25, 2021
Case Report: Circulating Myeloid-Derived Suppressive-Like Cells and Exhausted Immune Cells in Non-Small Cell Lung Cancer Patients Treated With Three Immune Checkpoint Inhibitors.
Journal: Frontiers in immunology
Published: February 25, 2021
Last Updated: 09/26/2026